Covea Finance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.2M Buy
36,010
+6,870
+24% +$7.02M 1.36% 18
2026
Q1
$26.8M Sell
29,140
-1,830
-6% -$1.86M 0.94% 33
2025
Q4
$33.3M Sell
30,970
-9,100
-23% -$8.7M 1.1% 27
2025
Q3
$30.6M Sell
40,070
-4,400
-10% -$3.27M 1.07% 31
2025
Q2
$34.7M Buy
44,470
+13,370
+43% +$10.4M 1.29% 25
2025
Q1
$25.7M Buy
+31,100
New +$25.9M 1.18% 28

Other funds holding LLY

Covea Finance's LLY Position: Q2 2026 in Review

Covea Finance increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $7.02M and bringing the position to 36,010 shares worth $43.2M. The position accounts for 1.36% of the portfolio, ranked #18.

Covea Finance first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Covea Finance held 36,010 shares of Eli Lilly worth $43.2M as of Q2 2026.
  • Covea Finance bought 6,870 Eli Lilly shares in Q2 2026, an estimated $7.02M.
  • Eli Lilly made up 1.36% of Covea Finance's portfolio in Q2 2026, its #18 holding.
  • Covea Finance first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.